Welgus Howard G.'s Form 4 filing
Arcutis Biotherapeutics, Inc.ARQT · filed Oct 19, 2026
- Accession no.
- 0001628280-26-066331
- Filed
- Oct 19, 2026, 4:49 PM ET
- Trade date
- Oct 15, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $127.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Welgus Howard G.CIK 0001801050 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Common Stock | MOption exerciseAcquired | +822 | $6.52 | +$5,361.33 | 36,663 | Direct | |
| Oct 15, 2026 | Common Stock | MOption exerciseAcquired | +1,018 | $7.51 | +$7,645.18 | 37,681 | Direct | |
| Oct 15, 2026 | Common Stock | MOption exerciseAcquired | +2,254 | $8.63 | +$19,452.02 | 39,935 | Direct | |
| Oct 15, 2026 | Common Stock | SSaleDisposed | −4,728 | $26.93 | −$127,325.04 | 35,207 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Common Stock | MOption exerciseDisposed | −822 | $0.00 | $0 | 5,752 | Direct | |
| Oct 15, 2026 | Common Stock | MOption exerciseDisposed | −1,018 | $0.00 | $0 | 7,126 | Direct | |
| Oct 15, 2026 | Common Stock | MOption exerciseDisposed | −2,254 | $0.00 | $0 | 15,778 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.